WASHINGTON, Sept. 25 -- Rep. Ami Bera, D-California, issued the following news release:

U.S. Representative Ami Bera, M.D. (D-CA-06), along with U.S. Representative Larry Bucshon, M.D. (R-IN-08) and eight additional bipartisan colleagues, recently introduced the Penicillin Allergy Verification and Evaluation (PAVE) Act. This legislation would add a penicillin allergy verification component to the "Welcome to Medicare" preventive visit and annual wellness visits.